Determining the Incidence of Rare Diseases - PubMed

Determining the Incidence of Rare Diseases - PubMed

Determining the Incidence of Rare Diseases

Matthew N Bainbridge 1

Affiliations 

• PMID: 32056000
 
• DOI: 10.1007/s00439-020-02135-5

Abstract

Extremely rare diseases are increasingly recognized due to wide-spread, inexpensive genomic sequencing. Understanding the incidence of rare disease is important for appreciating its health impact and allocating recourses for research. However, estimating incidence of rare disease is challenging because the individual contributory alleles are, themselves, extremely rare. We propose a new method to determine incidence of rare, severe, recessive disease in non-consanguineous populations that use known allele frequencies, estimate the combined allele frequency of observed alleles and estimate the number of causative alleles that are thus far unobserved in a disease cohort. Experiments on simulated and real data show that this approach is a feasible method to estimate the incidence of rare disease in European populations but due to several limitations in our ability to assess the full spectrum of pathogenic mutations serves as a useful tool to provide a lower threshold on disease incidence.

Keywords: Genetics; Incidence; Rare disease; Simulation.

Similar articles

• Prevalence Estimation for Monogenic Autosomal Recessive Diseases Using Population-Based Genetic Data

  SJ Schrodi et al. Hum Genet 134 (6), 659-69. Jun 2015. PMID 25893794.

  Genetic methods can complement epidemiological surveys and clinical registries in determining prevalence of monogenic autosomal recessive diseases. Several large populati …
• Insights Into the Genetic Epidemiology of Crohn's and Rare Diseases in the Ashkenazi Jewish Population

  MA Rivas et al. PLoS Genet 14 (5), e1007329. 2018. PMID 29795570.

  As part of a broader collaborative network of exome sequencing studies, we developed a jointly called data set of 5,685 Ashkenazi Jewish exomes. We make publicly availabl …
• Apparent Underdiagnosis of Cerebrotendinous Xanthomatosis Revealed by Analysis of ~60,000 Human Exomes

  V Appadurai et al. Mol Genet Metab 116 (4), 298-304. Dec 2015. PMID 26643207.

  Cerebrotendinous Xanthomatosis (CTX) is a treatable inborn error of metabolism caused by recessive variants in CYP27A1. Clinical presentation varies, but typically includ …
• Impact of New Genomic Tools on the Practice of Clinical Genetics in Consanguineous Populations: The Saudi Experience

  FS Alkuraya. Clin Genet 84 (3), 203-8. Sep 2013. PMID 23451714. - Review

  Consanguinity is practiced by around one tenth of the world population but its global distribution is far from uniform. In countries where consanguinity is common, a corr …
• HLA Allele Variation as a Potential Explanation for the Geographical Distribution of Granulomatosis With Polyangiitis

  RA Watts et al. Rheumatology (Oxford) 54 (2), 359-62. Feb 2015. PMID 25172939. - Review

  HLA-DPB1*0401 is a GPA susceptibility allele and HLA-DPB1*0401 population allele frequencies may help explain variations in GPA incidence described in the literature.